We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
NPC1 in human white adipose tissue and obesity
BMC Endocrine Disordersvolume 13, Article number: 5 (2013)
Genetic studies have implicated the NPC1 gene (Niemann Pick type C1) in susceptibility to obesity.
To assess the potential function of NPC1 in obesity, we determined its expression in abdominal white adipose tissue (WAT) in relation to obesity. NPC1 mRNA was measured by RT-qPCR in lean and obese individuals, paired samples of subcutaneous (sc) and omental (om) WAT, before and after weight loss, in isolated adipocytes and intact adipose pieces, and in primary adipocyte cultures during adipocyte differentiation. NPC1 protein was examined in isolated adipocytes.
NPC1 mRNA was significantly increased in obese individuals in scWAT and omWAT and downregulated by weight loss. NPC1 mRNA was enriched in isolated fat cells of WAT, in scWAT versus omWAT but not modified during adipocyte differentiation. NPC1 protein mirrored expression of mRNA in lean and obese individuals.
NPC1 is highly expressed in human WAT adipocytes with increased levels in obese. These results suggest that NPC1 may play a role in adipocyte processes underlying obesity.
Obesity is characterized by an excess of white adipose tissue (WAT) and marked adipocyte dysfunction that increase the risk for insulin resistance, type 2 diabetes mellitus and cardiovascular disease. White adipose tissue is not only energy reserve; it is also an active organ that contributes to whole body energy homeostasis by several different mechanisms. The underlying causes of obesity are complex and involve factors including caloric over-supply, a sedentary life-style, and a genetic predisposition.
A recent genome-wide association study report has indicated that the Niemann-Pick C1 gene (NPC1) is associated with early-onset and morbid adult obesity . The NPC1 protein regulates transport of lipoprotein-derived lipid (cholesterol and fatty acids) from late endosomes/lysosomes to other cellular compartments and is responsible for maintaining intracellular cholesterol homeostasis [2–4]. However, the human genome-wide association study did not address how the NPC1 gene variant promotes weight gain. Interestingly, a recent report showed that NPC1+/− male mice, when fed a high fat diet, deposited more fat and were heavier than their wild-type siblings in the absence of hyperphagia. They also developed adipocyte hypertrophy [5, 6]. This data suggest that NPC1 has a previously unknown role in maintaining energy and metabolic homeostasis.
Our interest in NPC1 was stimulated by these findings, which imply a role for NPC1 in obesity and potentially adipose metabolism. We have previously reported that NPC1 is highly expressed in human WAT . In this study we investigated the hypothesis that NPC1 is active within human WAT. We performed a more detailed profiling of NPC1 mRNA and protein levels in relation to obesity and mRNA in relation to regional adipose depots and cellular origin.
Cohorts and clinical investigation
Investigated cohorts are described in Table 1. Cohorts and clinical investigation were previously described in details . Obesity was defined as a BMI (body mass index) ≥30 kg/m2, whereas non-obesity was defined as BMI <30 kg/m2. Some subjects were examined before and 2–3 years after weight loss following either bariatric surgery or behavioral modification when a weight stable non-obese state had been reached. Subjects were recruited by local advertisement for the purpose of studying genes regulating obesity and fat cell function. Informed consent was obtained from all study subjects. The project was conducted in accordance with the guidelines in The Declaration of Helsinki and approved by the Regional Ethics committee in Stockholm, Sweden.
All subjects were healthy except for obesity and were investigated in the morning after a night’s fast. For those patients for which scWAT and omWAT were available, peroperative biopsies were obtained at the beginning of surgery. Only saline was given as intravenous infusion until adipose tissue was removed. For all other subjects, an abdominal subcutaneous WAT needle biopsy was obtained as previously described . Tissue pieces were rapidly rinsed in saline and subsequently frozen in liquid nitrogen and kept at −70°C.
Isolated fat cells were prepared according to the collagenase procedure as described . Mean fat cell weight and volume were determined; lipolysis and lipogenesis experiments were conducted as described [10, 11]. In some experiments we save the stroma fraction to prepare primary adipocyte cultures as previously described in details . Briefly, WAT was washed, cut into small pieces and digested with collagenase for 1 h at 37°C. The collagenase-treated cell suspension was centrifuged at 200 x g for 10 min and the supernatant, containing mature adipocytes and collagenase solution, was removed. The remaining stroma vacular fraction (containing preadipocytes and mesenhymal stem cells) was resuspended in erythrocyte lysis buffer for 10 min, filtered though a nylon mesh and centrifuged as above. The supernatant was discarded and the pellet suspended in an inoculation medium DMEM/F12 supplemented with 10 % fetal bovine serum, 100 μg/ml penicillin-streptomycin and subsequently filtered through a 70 μm pore size filter. The cells were plated at the density of 30.000-50.000 cells/cm2 in inoculation medium to allow cells attachment. After 24 h the medium was changed to differentiation medium (DMEM/F12 supplemented with 15 mM HEPES, 100 μg/ml penicillin-streptomycin, 2.5 μg/ml amphotericin B, 66 nM human insulin, 1 nM triiodo-L-thyroine, 10 μg/ml human transferrin, 33 μM biotin, 17 μM panthotenate, 100 nM cortisol and 10 μM rosiglitazone (BRL49653). Rosiglitazone was included first 3–6 days and then removed from the differentiation medium. NPC1 mRNA was quantified at day 4th, 8th, and 12th of differentiation in primary adipocyte cultures.
RNA isolation and quantification of gene expression
RNA extraction, measurements of concentration and purity as well as reverse transcription was carried out as described . RT-qPCR was performed using the SYBR Green-based technology. NPC1 was amplified with the primers 5’-AGCCAGTAATGTCACCGAAAC and 5’-CCGAGGTTGAAGATAGTGTCG or Taqman probes (Applied Biosystems, Foster City, CA). 18S amplified with described primers . Relative NPC1 expression calculated using the comparative Ct-method, i.e. 2ΔCt-target gene/2ΔCt-reference gene with 18S as internal control. Levels of 18S did not differ between groups.
Proteins from isolated adipocytes were prepared as described . Thirty five μg of total protein was separated by 7.5 % SDS-PAGE and Western blot was performed according to standard procedures. Primary antibodies against NPC1 were obtained from Life Span BioSciences, Inc. (Seattle, WA). Secondary antibodies were from Sigma-Aldrich. NPC1 protein was normalized to the most abundant protein band (bovine serum albumin) on the membrane visualized with Ponceau C (Sigma-Aldrich, St. Louis, MO). Images were analyzed using Quantity One Software (Bio-Rad Inc., Hercules, CA).
Differences in adipose tissue expression of individual genes between two groups were analyzed by Student’s t-test. Correlations between NPC1 expression and quantitative phenotypes were evaluated by regressions, when appropriate with BMI as additional independent parameter. Age was not correlated to NPC1 expression.
Adipose NPC1 expression in obesity
Both obese females and males displayed higher NPC1 mRNA levels in intact pieces of abdominal scWAT (P=<0.0001 and 0.002, respectively), when compared to non-obese subjects (Cohort 1, Figure 1A). NPC1 mRNA expression was also increased in omWAT (P= 0.013, Cohort 2, Figure 1B) of obese females. We did not have access to male omWAT. NPC1 mRNA levels were normalized by weight loss following either bariatric surgery or behavioral modification (P= 0.0452, Cohort 3, Figure 1C). Age did not influence NPC1 gene expression (values not shown).
The adipose source of NPC1 was also studied in more detail. NPC1 mRNA was higher expressed in scWAT than in omWAT (P= 0.0017, Cohort 2, Figure 2A). Moreover, NPC1 mRNA levels were about two-fold higher in isolated fat cells as compared to intact adipose tissue pieces (Cohort 5, Figure 2B, P=0.018). However, NPC1 expression was not altered during adipocyte differentiation as evidenced by the mRNA levels in primary adipocyte cultures at day 8 and 12 of differentiation relative to day 4 (Cohort 6, Figure 2C). To investigate if NPC1 protein levels reflect mRNA expression, we assessed NPC1 expression by Western blot in isolated fat cells of obese and lean subjects. Level of NPC1 protein was significantly higher in obese (P=0.0002, Cohort 7, Figure 2D).
To further explore the role of NPC1 in WAT, the associations between scWAT NPC1 mRNA levels and anthropological measurements, as well as phenotypes reflecting fat cell metabolism was determined (Figure 3). NPC1 mRNA was positively correlated with BMI (P<0.0001, r=0.473, Figure 3A), waist circumference (P<0.0001, r=0.533, Figure 3B) and fat cell volume (P<0.0001, r=0.429, Figure 3C). There was no association between NPC1 mRNA and levels of catecholamine-stimulated lipolysis or insulin-stimulated lipogenesis in adipocytes (data not shown).
The present detailed study of the obesity-gene NPC1 revealed that NPC1 mRNA levels were increased in both subcutaneous and omental fat depots, enriched in subcutaneous fat and isolated fat cells and down-regulated by weight loss. Adipose NPC1 protein mirrored the mRNA levels. Expression of NPC1 was stable during in vitro adipocyte differentiation. There was no gender-specific difference on NPC1 expression.
The correlation between NPC1 mRNA levels with BMI and waist circumference in humans clearly fits into the concept of NPC1 as an obesity gene. In agreement with this, humans affected by Niemann-Pick syndrome, with mutated NPC1 gene, show impaired gain and maintenance of body weight . However, in Niemann-Pick syndrome we do not know whether the NPC1 gene has a specific influence on fat accumulation, or whether the impaired weight gain is an unspecific effect due to chronic disease. As regards experimental models, both female and male mice with decreased NPC1 gene dosage gain weight on a high-fat diet . On the other hand, NPC1 gene is increased in livers of obese wild-type mice fed a high-fat diet . This upregulation of NPC1 in liver of obese mice mimic the effect we observe in human adipose tissue and could indicate that upregulation of NPC1 in obese subjects may be part of a pathway to counteract obesity. A similar paradoxical effect is observed for e.g. leptin, which counteracts obesity but still is increased in obese subjects . We demonstrate no gender impact to NPC1 expression in humans which is in concordance with the mice model.
Until recently, studies of NPC1 gene function have been mostly focused on the pathogenesis of the CNS disease even though that is a secondary neurological impairment of lipid accumulation. Our results of increased NPC1 levels in adipose tissue of obese subjects and the consequent normalization after weigh loss, as well as the association between NPC1 mRNA and fat cell size add impact on NPC1 function on visceral effects and support the concept of a metabolic function of NPC1 gene in adipose tissue.
NPC1 is enriched in fat cells of human adipose tissue, is elevated in obesity and affected by anti-obesity therapy. NPC1 may partially influence susceptibility to obesity by altering adipocyte function although further studies are needed to decipher its contribution to obesity development.
Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proenca C: Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009, 41 (2): 157-159. 10.1038/ng.301.
Garver WS, Heidenreich RA, Erickson RP, Thomas MA, Wilson JM: Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments. J Lipid Res. 2000, 41 (5): 673-687.
Higgins ME, Davies JP, Chen FW, Ioannou YA: Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab. 1999, 68 (1): 1-13. 10.1006/mgme.1999.2882.
Neufeld EB, Wastney M, Patel S, Suresh S, Cooney AM, Dwyer NK, Roff CF, Ohno K, Morris JA, Carstea ED: The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem. 1999, 274 (14): 9627-9635. 10.1074/jbc.274.14.9627.
Jelinek D, Heidenreich RA, Erickson RP, Garver WS: Decreased Npc1 gene dosage in mice is associated with weight gain. Obesity (Silver Spring). 2010, 18 (7): 1457-1459. 10.1038/oby.2009.415.
Jelinek D, Millward V, Birdi A, Trouard TP, Heidenreich RA, Garver WS: Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet. 2011, 20 (2): 312-321. 10.1093/hmg/ddq466.
Kulyte A, Ryden M, Mejhert N, Dungner E, Sjolin E, Arner P, Dahlman I: MTCH2 in human white adipose tissue and obesity. J Clin Endocrinol Metab. 2011, 96 (10): E1661-1665. 10.1210/jc.2010-3050.
Kolaczynski JW, Morales LM, Moore JH, Considine RV, Pietrzkowski Z, Noto PF, Colberg J, Caro JF: A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. Int J Obes Relat Metab Disord. 1994, 18 (3): 161-166.
Rodbell M: Localization of lipoprotein lipase in fat cells of rat adipose tissue. J Biol Chem. 1964, 239: 753-755.
Lofgren P, Hoffstedt J, Naslund E, Wiren M, Arner P: Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction. Diabetologia. 2005, 48 (11): 2334-2342. 10.1007/s00125-005-1961-6.
Arner P, Stenson BM, Dungner E, Naslund E, Hoffstedt J, Ryden M, Dahlman I: Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance. J Clin Endocrinol Metab. 2008, 93 (6): 2249-2254. 10.1210/jc.2008-0206.
van Harmelen V, Skurk T, Hauner H: Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med. 2005, 107: 125-135.
Jiao H, Arner P, Dickson SL, Vidal H, Mejhert N, Henegar C, Taube M, Hansson C, Hinney A, Galan P: Genetic association and gene expression analysis identify FGFR1 as a new susceptibility gene for human obesity. J Clin Endocrinol Metab. 2011, 96 (6): E962-966. 10.1210/jc.2010-2639.
Laurencikiene J, Skurk T, Kulyte A, Heden P, Astrom G, Sjolin E, Ryden M, Hauner H, Arner P: Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab. 2011, 96 (12): E2045-2049. 10.1210/jc.2011-1702.
Crocker AC, Farber S: Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore). 1958, 37 (1): 1-95. 10.1097/00005792-195802000-00001.
Jelinek DA, Maghsoodi B, Borbon IA, Hardwick RN, Cherrington NJ, Erickson RP: Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae. Gene. 2012, 491 (2): 128-134. 10.1016/j.gene.2011.10.010.
Garver WS, Horwood JL, Erickson RP, Heidenreich RA, Jelinek D, Meaney FJ: The Niemann-Pick C1 gene interacts with a high-fat diet to promote weight gain in young mice. Obesity. 2010, 18: S54-S54. 10.1038/oby.2009.432.
Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 1998, 395 (6704): 763-770. 10.1038/27376.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/13/5/prepub
We thank Elisabeth Dungner, Eva Sjölin, Gaby Åström, Kerstin Wåhlén, Britt-Marie Leijonhufvud, Katarina Hertel and Yvonne Widlund for excellent technical assistance. This work was supported by several grants from the Swedish Research Council, the Swedish Diabetes Foundation, the Diabetes Program at Karolinska Institutet and the Swedish Society of Medicine.
The authors declare that they have no competing interests.
ID and AK designed the study. CB, ID and AK acquired, analyzed, interpreted the data and drafted the manuscript. ID and PA collected patient material. PA revised the final version of the manuscript. All authors read and approved the final manuscript.